Edwards Lifesciences (EW) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended March 2025, Edwards Lifesciences (EW) reported revenue of $1.41 billion, down 11.6% over the same period last year. EPS came in at$ 0.64, compared to $0.66 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of$ 1.4 billion, representing a surprise of +0.71%. The company delivered an EPS surprise of +6.67%, with the consensus EPS estimate being $0.60. Here is how Edwards Lifesciences performed in the just reported quarter in terms of the metrics most ...